Paper21392552
Reduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia.
Li XF and 5 others. Prog Neuropsychopharmacol Biol Psychiatry, 2011. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. Reduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia. Papers, record 21392552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21392552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antioxidants | Major topic |
| Schizophrenia | Major topic |
| Adolescent | |
| Adult | |
| Asian People | |
| Body Mass Index | |
| Diagnostic and Statistical Manual of Mental Disorders | |
| Educational Status | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Neuropsychological Tests | |
| Oxidative Stress | |
| Schizophrenic Psychology | |
| Sex Characteristics | |
| Smoking | |
| Socioeconomic Factors | |
| Young Adult |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K05-DA0454 | NIDA NIH HHS | United States | K05DA000454 | PubMed and NIH | NIH RePORTER |
| P50-DA18827 | NIDA NIH HHS | United States | PubMed | PubMed | |
| U01-MH79639 | NIMH NIH HHS | United States | U01MH079639 | PubMed and NIH | NIH RePORTER |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41639905 | The predictive potential and relationship of peripheral non-enzymatic antioxidants with clinical symptoms in first-episode male adolescent-onset schizophrenia patients. | Ann Gen Psychiatry | 2026 | https://conductscience.org/library/papers/41639905 | PubMed |
| 41133635 | The Pathobiological Underpinnings of Psychosis: From the Stress-Related Hypothesis to a Multisystemic Approach. | NeuroSci | 2025 | https://conductscience.org/library/papers/41133635 | PubMed |
| 37859307 | Smoking, Symptoms Improvement, and Total Antioxidant Capacity in Patients with Drug-naive First-episode Schizophrenia: A Prospective Cohort Study. | Curr Neuropharmacol | 2024 | https://conductscience.org/library/papers/37859307 | PubMed |
| 37371989 | Age of Onset Moderates the Association between Total Antioxidant Capacity and Cognitive Deficits in Patients with Drug-Naïve Schizophrenia. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37371989 | PubMed |
| 36979300 | Oxidative Stress Biomarkers among Schizophrenia Inpatients. | Brain Sci | 2023 | https://conductscience.org/library/papers/36979300 | PubMed |
| 36295651 | Decreased Activity of Erythrocyte Catalase and Glutathione Peroxidase in Patients with Schizophrenia. | Medicina (Kaunas) | 2022 | https://conductscience.org/library/papers/36295651 | PubMed |
| 36290593 | Oxidative Stress and Emergence of Psychosis. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/36290593 | PubMed |
| 35269952 | Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35269952 | PubMed |
| 34867519 | Oxidative Stress Biomarkers as a Predictor of Stage Illness and Clinical Course of Schizophrenia. | Front Psychiatry | 2021 | https://conductscience.org/library/papers/34867519 | PubMed |
| 34366935 | Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders. | Front Psychiatry | 2021 | https://conductscience.org/library/papers/34366935 | PubMed |
| 33791970 | Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study. | Neurotherapeutics | 2021 | https://conductscience.org/library/papers/33791970 | PubMed |
| 31354881 | Plasma total antioxidant status and cognitive impairments in first-episode drug-naïve patients with schizophrenia. | Cogn Neurodyn | 2019 | https://conductscience.org/library/papers/31354881 | PubMed |
| 30498208 | Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients. | Transl Psychiatry | 2018 | https://conductscience.org/library/papers/30498208 | PubMed |
| 28934193 | Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia. | Transl Psychiatry | 2017 | https://conductscience.org/library/papers/28934193 | PubMed |
| 27574431 | Relationship between neutrophil/lymphocyte ratio with oxidative stress and psychopathology in patients with schizophrenia. | Neuropsychiatr Dis Treat | 2016 | https://conductscience.org/library/papers/27574431 | PubMed |
| 26029110 | Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects. | Front Physiol | 2015 | https://conductscience.org/library/papers/26029110 | PubMed |
| 25061527 | Polyphenols from Berries of Aronia melanocarpa Reduce the Plasma Lipid Peroxidation Induced by Ziprasidone. | Schizophr Res Treatment | 2014 | https://conductscience.org/library/papers/25061527 | PubMed |
| 23683390 | Meta-analysis of oxidative stress in schizophrenia. | Biol Psychiatry | 2013 | https://conductscience.org/library/papers/23683390 | PubMed |
| 23212700 | Association of SOD2, GPX1, CAT, and TNF genetic polymorphisms with oxidative stress, neurochemistry, psychopathology, and extrapyramidal symptoms in schizophrenia. | Neurochem Res | 2013 | https://conductscience.org/library/papers/23212700 | PubMed |
| 23123357 | Antioxidants as potential therapeutics for neuropsychiatric disorders. | Prog Neuropsychopharmacol Biol Psychiatry | 2013 | https://conductscience.org/library/papers/23123357 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21392552
GET https://conductscience.org/api/papers/v1/21392552/cited_by?page=2